NuvoAir AB

Company profile

About NuvoAir AB

NuvoAir AB is a remote patient monitoring company specializing in cardiopulmonary care for patients with complex heart and lung conditions. Founded with the mission to ensure no patient is left behind, NuvoAir has built a virtual-first care model that proactively diagnoses, monitors, and manages conditions such as COPD, asthma, heart failure, sleep apnea, and related cardiopulmonary diseases. The company's integrated platform combines FDA-cleared at-home monitoring devices with continuous remote monitoring, real-time data analytics, and a multidisciplinary care team of licensed nurses and physicians. NuvoAir serves three primary customer segments: health plans seeking to reduce hospitalizations and medical spend for high-risk members, healthcare providers looking to streamline chronic care management in both fee-for-service and value-based care models, and patients requiring accessible specialty care. The platform ingests clinical feeds, claims data, and device readings to stratify patients by risk, predict exacerbations before they escalate, and enable timely interventions. Services include on-site spirometry, digital pulmonology consults, personalized care plans, pulmonary rehabilitation, medication management, and virtual clinic access. With over 70 publications demonstrating clinical outcomes, NuvoAir has shown a 31% reduction in all-cause hospitalizations, 52% decrease in hospital days, 77% drop in readmissions, and 27% reduction in total medical spend. The company maintains 93% member engagement rates and Net Promoter Scores above 90. Headquartered in Boston with operations across two continents, NuvoAir is covered by over 100 health plans and partners with leading health systems and medical groups to deliver the next generation of cardiopulmonary care.

Company description · NuvoAir AB official website